HDAC9 and neoplasm: HDAC inhibitor can reverse this phenomenon and reactivate the expression of tumor suppressors, and HDAC inhibitor can act on histone acetylation and non-histone acetylation to inhibit tumor growth, invasion and metastasis, and has become a clinically effective anti-tumor drug (221) (Table 5).